Extracellular Superoxide Dismutase Expression in Papillary Thyroid Cancer Mesenchymal Stem/Stromal Cells Modulates Cancer Cell Growth and Migration-Reference-Cited by-同舟云学术

Extracellular Superoxide Dismutase Expression in Papillary Thyroid Cancer Mesenchymal Stem/Stromal Cells Modulates Cancer Cell Growth and Migration

Published:2017-02 Issue:1 Volume:7 Page:
ISSN:2045-2322
Container-title:Scientific Reports
language:en
Short-container-title:Sci Rep

Author:

Parascandolo Alessia,Rappa Francesca,Cappello Francesco,Kim Jaehyup,Cantu David A.,Chen Herbert,Mazzoccoli Gianluigi,Hematti Peiman,Castellone Maria Domenica,Salvatore Marco,Laukkanen Mikko O.

Publisher

Springer Science and Business Media LLC

Subject

Multidisciplinary

Link

http://www.nature.com/articles/srep41416.pdf

Reference61 articles.

1. Pastan, I. & Willingham, M. Cellular transformation and the ‘morphologic phenotype’ of transformed cells. Nature 274, 645–650, doi: 10.1038/274645a0 (1978).

2. Sachs, L. Constitutive uncoupling of the controls for growth and differentiation in myeloid leukemia and the development of cancer. J Natl Cancer Inst 65, 675–679 (1980).

3. Ghesquiere, B., Wong, B. W., Kuchnio, A. & Carmeliet, P. Metabolism of stromal and immune cells in health and disease. Nature 511, 167–176, doi: 10.1038/nature13312 (2014).

4. Di Mitri, D. & Alimonti, A. Non-Cell-Autonomous Regulation of Cellular Senescence in Cancer. Trends Cell Biol 26, 215–226, doi: 10.1016/j.tcb.2015.10.005 (2016).

5. Berindan-Neagoe, I., Monroig Pdel, C., Pasculli, B. & Calin, G. A. MicroRNAome genome: a treasure for cancer diagnosis and therapy. CA: a cancer journal for clinicians 64, 311–336, doi: 10.3322/caac.21244 (2014).

Cited by 31 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Advancements in theranostic applications: exploring the role of fibroblast activation protein inhibition tracers in enhancing thyroid health assessment;EJNMMI Research;2023-12-22

2. Clinical applications of fibroblast activation protein‐targeted theranostics in oncologic and nononcologic disease: Current status and future directions;iRADIOLOGY;2023-12

3. Fibroblast Activation Protein-Targeted Radioligand Therapy with 177Lu-EB-FAPI for Metastatic Radioiodine-Refractory Thyroid Cancer: First-in-Human, Dose-Escalation Study;Clinical Cancer Research;2023-10-06

4. Golgi-apparatus genes related signature for predicting the progression-free interval of patients with papillary thyroid carcinoma;BMC Medical Genomics;2023-03-27

5. A new molecular subclassification and in silico predictions for diagnosis and prognosis of papillary thyroid cancer by alternative splicing profile;Frontiers in Pharmacology;2023-03-06